Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (331-340 of 770) with videos related to

Pageof 77
Sort By:
European Heart Journal|October 18, 2007
Cardiovascular disease on a global scale: defining the path forward for research and practiceDaniel B Mark, Frans J Van de Werf, R John Simes, et al.
Circulation|April 23, 2003
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromesR Taylor Williams, Lakshmi V Damaraju, Mary Ann Mascelli, et al.
American Heart Journal|June 7, 2011
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionAnil Verma, Marc A Pfeffer, Hicham Skali, et al.
Lancet (London, England)|October 6, 2009
The role of academic health science systems in the transformation of medicineVictor J Dzau, D Clay Ackerly, Pamela Sutton-Wallace, et al.
American Heart Journal|March 29, 2008
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialPatricia J M Best, Steven R Steinhubl, Peter B Berger, et al.
American Heart Journal|December 18, 2007
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortalityKevin L Thomas, Sana M Al-Khatib, Yuliya Lokhnygina, et al.
The American Journal of Cardiology|September 5, 2006
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trialJames A de Lemos, Stephen D Wiviott, Sabina A Murphy, et al.
Global Heart|March 11, 2015
Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseasesGerald S Bloomfield, Tracy Y Wang, L Ebony Boulware, et al.
Pediatrics|September 3, 2008
Safety monitoring of drugs receiving pediatric marketing exclusivityP Brian Smith, Daniel K Benjamin, M Dianne Murphy, et al.
Journal of the American College of Cardiology|February 27, 2010
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge scoreChristopher M O'Connor, Vic Hasselblad, Rajendra H Mehta, et al.
Pageof 77

Showing results (331-340 of 770) with videos related to

Sort By:
Pageof 77
European Heart Journal|October 18, 2007
Cardiovascular disease on a global scale: defining the path forward for research and practiceDaniel B Mark, Frans J Van de Werf, R John Simes, et al.
Circulation|April 23, 2003
Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromesR Taylor Williams, Lakshmi V Damaraju, Mary Ann Mascelli, et al.
American Heart Journal|June 7, 2011
Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarctionAnil Verma, Marc A Pfeffer, Hicham Skali, et al.
Lancet (London, England)|October 6, 2009
The role of academic health science systems in the transformation of medicineVictor J Dzau, D Clay Ackerly, Pamela Sutton-Wallace, et al.
American Heart Journal|March 29, 2008
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialPatricia J M Best, Steven R Steinhubl, Peter B Berger, et al.
American Heart Journal|December 18, 2007
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortalityKevin L Thomas, Sana M Al-Khatib, Yuliya Lokhnygina, et al.
The American Journal of Cardiology|September 5, 2006
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trialJames A de Lemos, Stephen D Wiviott, Sabina A Murphy, et al.
Global Heart|March 11, 2015
Implementation of management strategies for diabetes and hypertension: from local to global health in cardiovascular diseasesGerald S Bloomfield, Tracy Y Wang, L Ebony Boulware, et al.
Pediatrics|September 3, 2008
Safety monitoring of drugs receiving pediatric marketing exclusivityP Brian Smith, Daniel K Benjamin, M Dianne Murphy, et al.
Journal of the American College of Cardiology|February 27, 2010
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge scoreChristopher M O'Connor, Vic Hasselblad, Rajendra H Mehta, et al.
Pageof 77